価格表

在庫・価格 : 2024年05月08日 08時21分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Human, Prostate Cancer Tissue, qPCR Array, Panel I(2), TissueScan
HPRT101 ORIオリジーン テクノロジーズ
OriGene Technologies, Inc.
1 kit ¥337,000
(未発注)
追加

在庫・価格 : 2024年05月08日 08時21分 現在

Human, Prostate Cancer Tissue, qPCR Array, Panel I(2), TissueScan

  • 商品コード:HPRT101
  • メーカー:ORI
  • 包装:1kit
  • 価格: ¥337,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Kim Y et al. The role of sLZIP in cyclin D3-mediated negative regulation of androgen receptor transactivation and its involvement in prostate cancer. Oncogene 2014 Jan;
Kim Y et al
2014/01/01
PubMed
2 Tannour-Louet M et al. Increased expression of CYP24A1 correlates with advanced stages of prostate cancer and can cause resistance to vitamin D3-based therapies. FASEB J. 2014 Jan;28(1):364-72
Tannour-Louet M et al
2014/01/01
PubMed
3 Orfanelli, U et al., Oncogene Jun 2014

PubMed
4 Orfanelli U et al. Antisense transcription at the TRPM2 locus as a novel prognostic marker and therapeutic target in prostate cancer. Oncogene 2015 Apr;34(16):2094-102
Orfanelli U et al
2015/01/01
PubMed
5 Honn KV et al. 12-HETER1/GPR31, a high-affinity 12(S)-hydroxyeicosatetraenoic acid receptor, is significantly up-regulated in prostate cancer and plays a critical role in prostate cancer progression. FASEB J. 2016 06;30(6):2360-9
Honn KV et al
2016/01/01
PubMed
  • No.: 1
  • 文献情報:
    Kim Y et al. The role of sLZIP in cyclin D3-mediated negative regulation of androgen receptor transactivation and its involvement in prostate cancer. Oncogene 2014 Jan;
    Kim Y et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Tannour-Louet M et al. Increased expression of CYP24A1 correlates with advanced stages of prostate cancer and can cause resistance to vitamin D3-based therapies. FASEB J. 2014 Jan;28(1):364-72
    Tannour-Louet M et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Orfanelli, U et al., Oncogene Jun 2014

  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Orfanelli U et al. Antisense transcription at the TRPM2 locus as a novel prognostic marker and therapeutic target in prostate cancer. Oncogene 2015 Apr;34(16):2094-102
    Orfanelli U et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Honn KV et al. 12-HETER1/GPR31, a high-affinity 12(S)-hydroxyeicosatetraenoic acid receptor, is significantly up-regulated in prostate cancer and plays a critical role in prostate cancer progression. FASEB J. 2016 06;30(6):2360-9
    Honn KV et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed